Characteristics of patients with micro-metastasis in SLN at OSNA
| Patient number | Age | FIGO stage | Histology | Grade | LVSI | Tumor diameter, mm (histology) | SLN mapping | Pelvic LND | Aortic LND | No of SLNs | Location of metastatic SLNs | No of metastatic SLNs | Type of metastasis in SLNs | No of positive non-SLN/total pelvic lymph nodes removed | No of copies CK19 mRNA (copies/μl) |
| #1 | 44 | IB1 | Adenocarcinoma | 2 | Negative | 18 | Bilateral | Yes | Yes | 2 | Right | 1 | Micro | 0/13 | 270 |
| #2 | 49 | IB1 | Adenocarcinoma | 1 | Negative | 13 | Bilateral | Yes | No | 3 | Left | 2 | Micro | 0/38 | 260; 400 |
| #3 | 31 | IB1 | SCC | 3 | Positive | 24 | Bilateral | Yes | No | 3 | Bilateral | 2 | Micro | 0/38 | 400; 960 |
| #4 | 46 | IB1 | Adenocarcinoma | 2 | Negative | 15 | Bilateral | Yes | Yes | 2 | Bilateral | 2 | Micro | 0/31 | 320; 290 |
| #5 | 41 | IB1 | SCC | 2 | Positive | 30 | Bilateral | Yes | Yes | 3 | Left | 1 | Micro | 0/10 | 2400 |
| #6 | 39 | IB1 | SCC | 2 | Positive | 26 | Bilateral | Yes | Yes | 3 | Right | 1 | Micro | 0/20 | 270 |
CK19, cytokeratin 19; CT-RT, chemo-radiotherapy; FIGO, International Federation of Gynecology and Obstetrics; LND, lymph node dissection; LVSI, lymph-vascular space involvement; MIC, micro-metastasis; NA, not applicable; NR, not reported; OSNA, one-step nucleic acid amplification; SCC, squamous cell carcinoma; SLN, sentinel lymph node.